Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) EPS (Weighted Average and Diluted): 2021-2025

Historic EPS (Weighted Average and Diluted) for CureVac N.V (CVAC) over the last 3 years, with Jun 2025 value amounting to $0.29.

  • CureVac N.V's EPS (Weighted Average and Diluted) fell 14.59% to $0.29 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.22, marking a year-over-year increase of 201.58%. This contributed to the annual value of $0.77 for FY2024, which is 160.60% up from last year.
  • As of Q2 2025, CureVac N.V's EPS (Weighted Average and Diluted) stood at $0.29, which was up 21.65% from $0.24 recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's EPS (Weighted Average and Diluted) registered a high of $0.99 during Q2 2021, and its lowest value of -$5.06 during Q4 2021.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.01, with a median of $0.29 in 2023.
  • In the last 5 years, CureVac N.V's EPS (Weighted Average and Diluted) crashed by 87.99% in 2022 and then surged by 222.77% in 2023.
  • Over the past 5 years, CureVac N.V's EPS (Weighted Average and Diluted) (Quarterly) stood at -$5.06 in 2021, then skyrocketed by 60.45% to -$2.00 in 2022, then dropped by 6.00% to -$2.12 in 2023, then climbed by 5.49% to $0.34 in 2024, then declined by 14.59% to $0.29 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.29 in Q2 2025, compared to $0.24 in Q1 2025 and $0.34 in Q2 2024.